Literature DB >> 15661030

Molecular and cellular pathogenesis of X-linked lymphoproliferative disease.

Kim E Nichols1, Cindy S Ma, Jennifer L Cannons, Pamela L Schwartzberg, Stuart G Tangye.   

Abstract

X-linked lymphoproliferative disease (XLP) is an inherited immune defect caused by mutations in the Src homology 2 domain-containing gene 1A, which encodes the adapter protein, signaling lymphocytic activation molecule (SLAM)-associated protein (SAP). SAP is expressed in T cells, natural killer (NK) cells, and NKT cells, where it binds to the cytoplasmic domain of the surface receptor SLAM (CD150) and the related receptors, 2B4 (CD244), CD84, Ly9 (CD229), NK-T-B-antigen, and CD2-like receptor-activating cytotoxic T cells. SAP also binds to the Src family tyrosine kinase Fyn and recruits it to SLAM, which leads to the generation of downstream phosphotyrosine signals. While the roles of the SLAM family receptors are only beginning to be understood, experiments suggest that these molecules regulate important aspects of lymphocyte function, such as proliferation, cytokine secretion, cytotoxicity, and antibody production. Thus, in XLP patients who lack functional SAP, the SLAM family receptors may not signal properly. This property likely contributes to the phenotypes of XLP, including fulminant infectious mononucleosis, lymphoma, and hypogammaglobulinemia. Further studies of SAP and the SLAM family receptors will provide insights into XLP and elucidate the signaling events regulating lymphocyte ontogeny and function.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15661030     DOI: 10.1111/j.0105-2896.2005.00230.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  64 in total

1.  X-linked lymphoproliferative disease due to SAP/SH2D1A deficiency: a multicenter study on the manifestations, management and outcome of the disease.

Authors:  Claire Booth; Kimberly C Gilmour; Paul Veys; Andrew R Gennery; Mary A Slatter; Helen Chapel; Paul T Heath; Colin G Steward; Owen Smith; Anna O'Meara; Hilary Kerrigan; Nizar Mahlaoui; Marina Cavazzana-Calvo; Alain Fischer; Despina Moshous; Stephane Blanche; Jana Pachlopnik Schmid; Jana Pachlopnick-Schmid; Sylvain Latour; Genevieve de Saint-Basile; Michael Albert; Gundula Notheis; Nikolaus Rieber; Brigitte Strahm; Henrike Ritterbusch; Arjan Lankester; Nico G Hartwig; Isabelle Meyts; Alessandro Plebani; Annarosa Soresina; Andrea Finocchi; Claudio Pignata; Emilia Cirillo; Sonia Bonanomi; Christina Peters; Krzysztof Kalwak; Srdjan Pasic; Petr Sedlacek; Janez Jazbec; Hirokazu Kanegane; Kim E Nichols; I Celine Hanson; Neena Kapoor; Elie Haddad; Morton Cowan; Sharon Choo; Joanne Smart; Peter D Arkwright; Hubert B Gaspar
Journal:  Blood       Date:  2010-10-06       Impact factor: 22.113

2.  X-linked lymphoproliferative disease associated with hypogammaglobulinemia and growth-hormone deficiency.

Authors:  Abdullah Alangari; Abdullah Abobaker; Hirokazu Kanegane; Toshio Miyawaki
Journal:  Eur J Pediatr       Date:  2005-11-17       Impact factor: 3.183

Review 3.  Immunity to microbes: lessons from primary immunodeficiencies.

Authors:  Magda Carneiro-Sampaio; Antonio Coutinho
Journal:  Infect Immun       Date:  2007-02-05       Impact factor: 3.441

4.  A novel ICOS-independent, but CD28- and SAP-dependent, pathway of T cell-dependent, polysaccharide-specific humoral immunity in response to intact Streptococcus pneumoniae versus pneumococcal conjugate vaccine.

Authors:  Quanyi Chen; Jennifer L Cannons; James C Paton; Hisaya Akiba; Pamela L Schwartzberg; Clifford M Snapper
Journal:  J Immunol       Date:  2008-12-15       Impact factor: 5.422

Review 5.  IAPs: what's in a name?

Authors:  Srinivasa M Srinivasula; Jonathan D Ashwell
Journal:  Mol Cell       Date:  2008-04-25       Impact factor: 17.970

6.  Contributions of matrix and large protein genes of the measles virus edmonston strain to growth in cultured cells as revealed by recombinant viruses.

Authors:  Maino Tahara; Makoto Takeda; Yusuke Yanagi
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

Review 7.  Rheumatologic and autoimmune manifestations of primary immunodeficiency disorders.

Authors:  Ramona Goyal; Ariel C Bulua; Nikolay P Nikolov; Pamela L Schwartzberg; Richard M Siegel
Journal:  Curr Opin Rheumatol       Date:  2009-01       Impact factor: 5.006

Review 8.  X-linked lymphoproliferative disease (XLP): a model of impaired anti-viral, anti-tumor and humoral immune responses.

Authors:  Hamid Bassiri; W C Janice Yeo; Jennifer Rothman; Gary A Koretzky; Kim E Nichols
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

9.  Frequent mutations in SH2D1A (XLP) in males presenting with high-grade mature B-cell neoplasms.

Authors:  J T Sandlund; S A Shurtleff; M Onciu; E Horwitz; W Leung; V Howard; R Rencher; M E Conley
Journal:  Pediatr Blood Cancer       Date:  2013-04-15       Impact factor: 3.167

10.  A novel primary immunodeficiency with specific natural-killer cell deficiency maps to the centromeric region of chromosome 8.

Authors:  Celine Eidenschenk; Jean Dunne; Emmanuelle Jouanguy; Claire Fourlinnie; Laure Gineau; Delphine Bacq; Corrina McMahon; Owen Smith; Jean-Laurent Casanova; Laurent Abel; Conleth Feighery
Journal:  Am J Hum Genet       Date:  2006-02-17       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.